Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Merck's Keytruda on its own, according to researchers. 

Share:
More In Science
Report: Pregnant Women Show Vaccine Hesitancy
The Centers for Disease Control and Prevention recently recommended for the first time that pregnant people get the RSV vaccine to protect their babies from severe disease but a recent report found concerns about vaccinations during pregnancy.
Load More